US Patent Issued to Cornell University on March 25 for "Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer" (New York Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,339, issued on March 25, was assigned to Cornell University (Ithaca, N.Y.).

"Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer" was invented by John W. Babich (New York), Justin Wilson (Ithaca, N.Y.), Nikki Thiele (Brooktondale, N.Y.), James Kelly (New York) and Shashikanth Ponnala (Ithaca, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology provides compounds as well as compositions including such compounds useful in targeted radiotherapy of cancer and/or mammalian tissue overexpressing prostate specific membrane antigen ("PSMA") where the compounds are represented by the ...